Who is eligible for clinical trial NCT02726763?

Participants must meet protocol criteria for Breast Cancer Survivors. Confirm exact inclusion and exclusion requirements with the study coordinator.

Does clinical trial NCT02726763 provide travel or cost reimbursement?

Check with the site coordinator at the participating facility for travel and lodging stipend availability, and for which routine-care costs are covered.

🏛️ Verified NIH Record • Updated 2026-04-22

Feasibility and Tolerability of Transcranial Direct Current Stimulation With Concurrent Cognitive Training (NCT02726763)

🔵 Active, Not Recruiting Observational / Diagnostic ⚙️ Medical Device Protocol Sponsor: Memorial Sloan Kettering Cancer Center

🩺 Plain-English Summary (8th-Grade Level)

In this study, the investigators are testing transcranial direct current stimulation (tDCS) in breast cancer survivors. In this pilot study, the investigators want to learn if it is feasible to use this device in memory rehabilitation.

Who can join: To join this study, participants generally need to meet the listed inclusion criteria (7 items) and avoid the listed exclusions (7 items).

Location: Memorial Sloan Kettering Cancer Center — New York, New York

📋 "Do I Qualify?" — 1-Minute Self Screener

Instant Checklist

Check every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).

Breast cancer survivors treated with chemotherapy between 40 and 65 years of age with no evidence of disease with treatment completed at least six months prior to study participation with or without current endocrine therapy.
Self-reported new onset since initiation of treatment cognitive dysfunction as determined by telephone screen using the brief (3 questions) assessment established by Ercoli et al. \[3\] (endorsement on all three questions):
Do you think or feel that your memory or mental ability has gotten worse since you completed your breast cancer treatment?
Do you think that your mind isn't as sharp now as it was before your breast cancer treatments?
Do you feel like these problems have made it harder to function on your job or take care of things around the home?
In the judgment of the investigators and/or consenting professional, able to read and comprehend English
In the judgment of the consenting professional cognitively able to provide informed consent

Usually NOT eligible if any of the following apply:

Exclusion Criteria:
Patients with prior history of primary Central Nervous System (CNS) cancer or CNS metastases
As per self report and/or medical record history of diagnosed neurological illness including seizure disorder, a dementing condition, or other neurological illness (multiple sclerosis, history of cerebrovascular accident, etc.)
Participants with untreated depression or anxiety as assessed by self-report and review of medical history;
Participants with a history of treated or untreated schizophrenia or bipolar disorder as assessed by self report and review of medical history;
As per self report participants who are pregnant or who are breastfeeding
As per self report participants with pacemakers, intracranial electrodes, implanted defibrillators or any other prosthesis.

🔍 Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.

📍 All Participating Trial Locations (1 Sites)

Memorial Sloan Kettering Cancer Center — New York, New York

💰 Cost, Insurance & Patient Rights

100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

🏛️ View Official NIH Record ↗